Cite
HARVARD Citation
Yarur, A. et al. (n.d.). Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis. Inflammatory bowel diseases. 22 (2), pp. 409-415. [Online].